prikaz prve stranice dokumenta Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with SGA
  Download
PDF 158.5 KB
Scientific paper - Original scientific paper
Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with SGA
Psychiatry Research, 189 (2011), 1; 21-25. https://doi.org/10.1016/j.psychres.2010.11.021
Vuksan-Ćusa, Bjanka; Jakovljević, Miro; Šagud, Marina; Mihaljević Peleš, Alma; Marčinko, Darko; Topić, Radmila; Mihaljević, Sanea; Sertić, Jadranka

Institutional repository: Dr Med - University of Zagreb School of Medicine Digital Repository

Cite this document

Vuksan Ćusa, B., Jakovljević, M., Šagud, M., Mihaljević Peleš, A., Marčinko, D., Topić, R. ... Sertić, J. (2011). Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with SGA. Psychiatry Research, 189. (1), 21-25. doi: 10.1016/j.psychres.2010.11.021

Vuksan Ćusa, Bjanka, et al. "Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with SGA." Psychiatry Research, vol. 189, no. 1, 2011, pp. 21-25. https://doi.org/10.1016/j.psychres.2010.11.021

Vuksan Ćusa, Bjanka, Miro Jakovljević, Marina Šagud, Alma Mihaljević Peleš, Darko Marčinko, Radmila Topić, Sanea Mihaljević and Jadranka Sertić. "Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with SGA." Psychiatry Research 189, no. 1 (2011): 21-25. https://doi.org/10.1016/j.psychres.2010.11.021

Vuksan Ćusa, B., et al. (2011) 'Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with SGA', Psychiatry Research, 189(1), pp. 21-25. doi: 10.1016/j.psychres.2010.11.021

Vuksan Ćusa B, Jakovljević M, Šagud M, Mihaljević Peleš A, Marčinko D, Topić R, and sur.. Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with SGA. Psychiatry Research [Internet]. 2011 August 30 [cited 2024 April 29];189(1):21-25. doi: 10.1016/j.psychres.2010.11.021

B. Vuksan Ćusa, et al., "Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with SGA", Psychiatry Research, vol. 189, no. 1, pp. 21-25, August 2011. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:887958. [Accessed: 29 April 2024]

Metadata
Title (english)Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with SGA
AuthorBjanka Vuksan-Ćusa
AuthorMiro Jakovljević
AuthorMarina Šagud
AuthorAlma Mihaljević Peleš
AuthorDarko Marčinko
AuthorRadmila Topić
AuthorSanea Mihaljević
AuthorJadranka Sertić
Author's institutionUniversity of Zagreb
School of Medicine
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
There is accumulating evidence for an increased prevalence of metabolic syndrome (MetS) in bipolar patients, which is comparable to the prevalence of MetS in patients with schizophrenia. Hyperhomocysteinaemia has emerged as an independent and graded risk factor for the development of cardiovascular disease (CVD), which is, at the same time, the primary clinical outcome of MetS. The aim of this study was to ascertain if the presence of MetS was associated with hyperhomocysteinaemia in patients with bipolar disorder (N=36) and schizophrenia (N=46) treated with second-generation antipsychotics (SGA). MetS was defined according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP-III) criteria and the cut-off point for hyperhomocysteinaemia was set up at 15μmoll(-1). Results of the study indicated that the presence of the MetS is statistically significantly associated with the elevated serum homocysteine in all participants. As hyperhomocysteinaemia has emerged as an independent risk factor for psychiatric disorder and CVD, it could be useful to include fasting homocysteine serum determination in the diagnostic panels of psychiatric patients to obtain a better assessment of their metabolic risk profile.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review
Publication versionAccepted version
Journal titlePsychiatry Research
Numberingvol. 189, no. 1, pp. 21-25
p-ISSN0165-1781
DOIhttps://doi.org/10.1016/j.psychres.2010.11.021
URN:NBNurn:nbn:hr:105:887958
Publication2011-08-30
Document URLhttps://doi.org/10.1016/j.psychres.2010.11.021
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2024-03-28 12:00:20